BR112022010038A2 - Composições de hialuronidase e métodos de uso das mesmas para tratar o encovamento periorbital e deformidades do sulco lacrimal - Google Patents

Composições de hialuronidase e métodos de uso das mesmas para tratar o encovamento periorbital e deformidades do sulco lacrimal

Info

Publication number
BR112022010038A2
BR112022010038A2 BR112022010038A BR112022010038A BR112022010038A2 BR 112022010038 A2 BR112022010038 A2 BR 112022010038A2 BR 112022010038 A BR112022010038 A BR 112022010038A BR 112022010038 A BR112022010038 A BR 112022010038A BR 112022010038 A2 BR112022010038 A2 BR 112022010038A2
Authority
BR
Brazil
Prior art keywords
periorbital
methods
lacrimal
treat
pulling
Prior art date
Application number
BR112022010038A
Other languages
English (en)
Inventor
E Sweis Iliana
C Cressey Bryan
Original Assignee
Standard Of Care Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Standard Of Care Corp filed Critical Standard Of Care Corp
Publication of BR112022010038A2 publication Critical patent/BR112022010038A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01036—Hyaluronoglucuronidase (3.2.1.36)

Abstract

COMPOSIÇÕES DE HIALURONIDASE E MÉTODOS DE USO DAS MESMAS PARA TRATAR O ENCOVAMENTO PERIORBITAL E DEFORMIDADES DO SULCO LACRIMAL. A presente invenção refere-se, em geral, a métodos e composições que compreendem uma proteína com atividade de hialuronidase para diagnosticar a etiologia, minimizar e tratar o encovamento periorbital com ou sem doença de tireoide associada e para tratar deformidades de sulco lacrimal.
BR112022010038A 2019-11-26 2020-11-24 Composições de hialuronidase e métodos de uso das mesmas para tratar o encovamento periorbital e deformidades do sulco lacrimal BR112022010038A2 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201962940748P 2019-11-26 2019-11-26
US201962940740P 2019-11-26 2019-11-26
US201962940747P 2019-11-26 2019-11-26
US202062966775P 2020-01-28 2020-01-28
US202062967775P 2020-01-30 2020-01-30
PCT/US2020/062050 WO2021108426A1 (en) 2019-11-26 2020-11-24 Hyaluronidase compositions and methods of using same to treat peri-orbital hollowness and tear through deformities

Publications (1)

Publication Number Publication Date
BR112022010038A2 true BR112022010038A2 (pt) 2022-08-16

Family

ID=76129681

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022010038A BR112022010038A2 (pt) 2019-11-26 2020-11-24 Composições de hialuronidase e métodos de uso das mesmas para tratar o encovamento periorbital e deformidades do sulco lacrimal

Country Status (4)

Country Link
US (1) US20230012731A1 (pt)
EP (1) EP4044973A4 (pt)
BR (1) BR112022010038A2 (pt)
WO (1) WO2021108426A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774695B2 (ja) * 1991-03-29 1998-07-09 コラーゲン コーポレイション 顔のしわを処置する装置および方法
AU2007243334A1 (en) * 2006-04-26 2007-11-08 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling
MX2009004198A (es) * 2006-10-17 2009-10-19 Lithera Inc Metodos, composiciones y formulaciones para el tratamiento de enfermedad ocular tiroidea.
US10906969B2 (en) * 2016-06-13 2021-02-02 Massachusetts Eye And Ear Infirmary Local orbital therapy for thyroid eye disease

Also Published As

Publication number Publication date
US20230012731A1 (en) 2023-01-19
EP4044973A1 (en) 2022-08-24
EP4044973A4 (en) 2023-03-08
WO2021108426A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
BR112022017930A2 (pt) Anticorpos anticoronavírus e métodos de uso
BR112022007677A2 (pt) L-asparaginase recombinante
BRPI0507442B8 (pt) método in vitro de diagnóstico de um indivíduo humano gestante como apresentando ou com uma propensão a desenvolver pré-eclâmpsia ou eclâmpsia
CL2019001258A1 (es) Métodos para tratar el síndrome de alport usando bardoxolona metilo o análogos de la misma.
EA201792447A1 (ru) Способы и композиции для диагностики и лечения заболеваний у пациентов, имеющих повышенные уровни cxcl9 и других биомаркеров
AR115583A1 (es) Composiciones y métodos para el tratamiento de las enfermedades y trastornos del hígado
BR112022011902A2 (pt) Terapias de combinação
BR112022011483A2 (pt) Composições de proteína para produtos alimentares à base de plantas e métodos para fabricação
BR112019001039A2 (pt) composição para uso no tratamento de transtorno depressivo maior
BR112019007843A2 (pt) métodos para prevenção de eventos cardiovascu-lares através da redução de proteína pró-proteina convertase subtilisina/quexina tipo 9 (pcsk9)
CL2020003008A1 (es) Estimulador de treg selectivo rur20kd-il-2 y composiciones relacionadas
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
BR112022005711A2 (pt) Métodos e composições para tratar uma doença ou transtorno
EA202092748A1 (ru) Модуляторы экспрессии apol1
BR112022010385A2 (pt) Uso de inibidores de sglt-2 na secagem de mamíferos não humanos
EA201992170A1 (ru) Модуляторы экспрессии pcsk9
BR112022007010A2 (pt) Terapia gênica para doença de alzheimer
BR112016013800A2 (pt) Composições e métodos para reduzir alérgenos de gatos no ambiente
MX2021010467A (es) Biomarcadores para dolencias articulares y usos de estos.
MX2022006073A (es) Metodos para utilizar anticuerpos anti-trem2.
BR112022009279A2 (pt) Tratamento de angioedema hereditário com vetores de terapia gênica específicos do fígado
BR112021018688A2 (pt) Composição para prevenir ou tratar doença cerebral e do sistema nervoso
BR112022010038A2 (pt) Composições de hialuronidase e métodos de uso das mesmas para tratar o encovamento periorbital e deformidades do sulco lacrimal
BR112016017349A2 (pt) métodos para melhorar os subprodutos de processos de fermentação usando xilanase
CO2021003136A2 (es) Terapias de combinación